- Many waste streams require specialized disposal methods, limiting opportunities for recycling.
- Relatively small-scale nature of operations limits environmental impact reduction opportunities.
Nykode Therapeutics ASA
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Nykode Therapeutics ASA disclosed greenhouse gas emissions of 5.4K tCO2e (location based). By scope: Scope 1: 0.46 tCO2e; Scope 2: 141.4 tCO2e (market based), 5.84 tCO2e (location based); Scope 3: 5.3K tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
5.4K tCO2e (location based)
2023
Waste
3.337 tons
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 0.46 tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 141.4 tCO2e (market based), 5.84 tCO2e (location based) |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 5.3K tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Implemented simple GHG reduction initiatives.
- Refined approach to waste minimization.
🌱 ESG Focus Areas
Climate and GHG emissionsEnvironmental impact and complianceWaste & RecyclingRecruitment, Training, and DevelopmentDiversity, Equity, and InclusionEmployment PracticesHealth and Safety of our EmployeesSocially Responsible Practices and TrialsEthical Business PracticesRegulatory ComplianceSustainable Supply Chain